Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Acelyrin Inc
(NQ:
SLRN
)
4.780
-0.030 (-0.62%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Acelyrin Inc
< Previous
1
2
3
4
Next >
ACELYRIN, INC. Reports Third Quarter 2023 Financial Results and Recent Highlights
November 07, 2023
From
ACELYRIN, INC.
Via
GlobeNewswire
ACELYRIN, INC. Appoints Patricia Turney as Chief Technical Operations Officer
November 06, 2023
From
Acelyrin, Inc.
Via
GlobeNewswire
ACELYRIN, INC. to Report Third Quarter 2023 Financial Results and Corporate Update on November 7, 2023
October 31, 2023
From
Acelyrin, Inc.
Via
GlobeNewswire
NASDAQ:SLRN Investor Notice: Investigation over Potential Wrongdoing at Acelyrin, Inc.
October 31, 2023
San Diego, CA -- (SBWIRE) -- 10/31/2023 -- Certain directors of Acelyrin, Inc. are under investigation over potential breaches of fiduciary duties.
Via
SBWire
Bragar Eagel & Squire, P.C. Is Investigating Acelyrin, and Clorox and Encourages Investors to Contact the Firm
October 18, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Acelyrin, Inc. (SLRN) on Behalf of Investors
October 13, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Acelyrin, Inc. (SLRN) on Behalf of Investors
October 12, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Acelyrin, Inc. (SLRN) on Behalf of Investors
October 12, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
NASDAQ:SLRN Shareholder Notice: Investigation over Possible Securities Laws Violations by Acelyrin, Inc.
October 06, 2023
San Diego, CA -- (SBWIRE) -- 10/06/2023 -- An investigation was announced over potential securities laws violations by Acelyrin, Inc in connection with certain financial statements.
Via
SBWire
ACELYRIN, INC. Scales for Continued Late-Stage Growth with The Appointment of Dr. Shephard Mpofu as Senior Vice President of Development
October 03, 2023
From
Acelyrin, Inc.
Via
GlobeNewswire
ACELYRIN ALERT: Bragar Eagel & Squire, P.C. is Investigating Acelyrin, Inc. on Behalf of Acelyrin Stockholders and Encourages Investors to Contact the Firm
September 28, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
ACELYRIN, INC. Announces Top-Line Results from Placebo-Controlled Clinical Trial of Izokibep for Moderate-to-Severe Hidradenitis Suppurativa
September 11, 2023
From
Acelyrin, Inc.
Via
GlobeNewswire
ACELYRIN, INC. to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
September 06, 2023
From
Acelyrin, Inc.
Via
GlobeNewswire
ACELYRIN, INC. Reports Second Quarter 2023 Financial Results and Recent Highlights
August 14, 2023
From
Acelyrin, Inc.
Via
GlobeNewswire
ACELYRIN, INC. to Present Second Quarter 2023 Financial Results and Corporate Update on August 14, 2023
August 07, 2023
From
Acelyrin, Inc.
Via
GlobeNewswire
ACELYRIN, INC. Appoints Ken Lock as Chief Commercial Officer
July 18, 2023
From
Acelyrin, Inc.
Via
GlobeNewswire
ACELYRIN, INC. Reports First Quarter 2023 Financial Results and Recent Highlights
June 15, 2023
From
Acelyrin, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.